Glycosylated hemoglobin as a marker of dyslipidemia in type 2 diabetes mellitus patients in a tertiary care hospital

Journal Title: International Archives of Integrated Medicine - Year 2017, Vol 4, Issue 2

Abstract

Introduction: In persons with diabetes, chronic hyperglycemia (assessed by glycosylated hemoglobin level) is related to the development of micro vascular disease; however, the relation of glycosylated hemoglobin to macro vascular disease is less clear. Glycosylated hemoglobin (HbA1c) is a more stable, accurate parameter of glucose homeostasis than fasting glycemia, thus providing prognostic information in diabetics. However, its role and relationship with CAD remains unclear in non-diabetics. Diabetic patients with accompanied (but often unnoticed) dyslipidemia are soft targets of cardiovascular deaths. Glycated hemoglobin (HbA1c) is a routinely used marker for long – term glycemic control. This investigation is an attempt to evaluate the association between HbA1c and various lipid parameters. Aim and objectives: To know the prevalence of dyslipidemias associated with type 2 DM, To study the impact of the glycemic status on lipid profile in type 2 DM, To evaluate the efficacy of HbA1c as a marker of dyslipidemia in type 2 DM. Materials and methods: Venous blood samples collected from 35 type 2 diabetic patients (20 males, 15 females) and serum analyzed for HbA1c, Fasting blood glucose, Total Cholesterol, triglycerides, HDL-C and LDL-C. L/H risk ratio is also calculated. A detailed history with thorough systemic examination was carried out. Hemogram, urinalysis, fasting and blood sugar after 2 h of major meal, HbA1c, lipid profile, performed. Results: We used student t-test and Pearson’s correlation coefficient to find the statistical significance. Result: serum concentration of glycated hemoglobin and all the parameters of lipid profile except HDL-C were increased while HDL-C concentration decreased in both the types of DM as compared to that of control. Conclusion: Dyslipidemia is more prominent in type-2 DM than that in type-1 DM. Glycemic control is poorer & its correlation with lipid profile is stronger in type-2 DM.

Authors and Affiliations

A. Valarmathi, Lalbahadur Sastri

Keywords

Related Articles

A comparison of ropivacaine with fentanyl to bupivacaine with fentanyl for post-operative patient controlled epidural analgesia in patients undergone lower abdominal cancer surgery

Background: PCEA (patient controlled epidural analgesia) is a safe and effective technique for post-operative analgesia on routine surgical wards. Use of the epidural catheter as part of a combined epidural-general anest...

A study on risk profile in acute ischemic stroke patients at Urban Medical College, Tamil Nadu

Background: Risk factor modification remains as the principal aspect of care for stroke prevention. Understanding of risk factors has advanced and several options are now available to treat modifiable risk factors. Preve...

Neurological soft signs in first episode psychotic disorder - A case control study

Introduction: Neurological signs, are traditionally classified into “Hard” and “Soft” signs. Soft signs are defined as minor, nonlocalizable, objective abnormalities that are thought to reflect damage in connections betw...

Identification of synthetic food colors adulteration by paper chromatography and spectrophotometric methods

Synthetic food colors are widely used in different types of food stuffs in India as well as in the world. Changing lifestyles across the globe have transformed food habit patterns. The instant and processed foods (junk f...

Clinical profile of Acute Pancreatitis in Malwa region of Punjab and its correlation with Balthazar CT Severity Index

Background: Acute pancreatitis is a common condition with wide clinical variation, ranging from mild self-limiting pancreatic inflammation to extensive pancreatic necrosis with life-threatening consequences. The present...

Download PDF file
  • EP ID EP408191
  • DOI -
  • Views 130
  • Downloads 0

How To Cite

A. Valarmathi, Lalbahadur Sastri (2017). Glycosylated hemoglobin as a marker of dyslipidemia in type 2 diabetes mellitus patients in a tertiary care hospital. International Archives of Integrated Medicine, 4(2), 21-25. https://europub.co.uk/articles/-A-408191